These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 5280477)

  • 1. Monocytic and monomyelocytic leukaemia with increased serum and urine lysozyme as a late complication in plasma cell myeloma.
    Osserman EF
    Br Med J; 1971 May; 2(5757):327. PubMed ID: 5280477
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia.
    Osserman EF; Lawlor DP
    J Exp Med; 1966 Nov; 124(5):921-52. PubMed ID: 5224561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myeloma and myelomonocytic leukemia. Role of melphalan. Ultrastructural and cytoenzymologic study].
    Marsan C; Henon P; Quillard A; Grimaldi A; Cywiner-Golenzer C; Adotti F; Dryll A; Roujeau J
    Pathol Eur; 1973; 8(4):287-98. PubMed ID: 4523953
    [No Abstract]   [Full Text] [Related]  

  • 4. Myeloma renal disease: evaluation of the role of muramidase (lysozyme).
    Rudders RA; Bloch KJ
    Am J Med Sci; 1971 Aug; 262(2):79-85. PubMed ID: 4111010
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum, urine, and leukocyte muramidase (lysozyme) activity in monocytic leukemia and other hematologic malignancies.
    Ota H; Nagase H
    Nihon Ketsueki Gakkai Zasshi; 1971 Aug; 34(4):498-512. PubMed ID: 5292814
    [No Abstract]   [Full Text] [Related]  

  • 6. Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy.
    Alexanian R; Migliore PJ
    J Lab Clin Med; 1970 Feb; 75(2):225-33. PubMed ID: 5414404
    [No Abstract]   [Full Text] [Related]  

  • 7. [Multiple myeloma terminating in leukemia].
    Manor Y; Steiner Z; Klajman A; Rozenszajn A
    Harefuah; 1978 Feb; 94(3-4):115-9. PubMed ID: 275198
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of 1-phenylalanine mustard on anti-globulin antibodies in multiple myeloma.
    Waller M; Moon JH; Irby R; Toone EC
    Clin Exp Immunol; 1971 Jan; 8(1):91-100. PubMed ID: 4993198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring myelomatosis.
    Hobbs JR
    Arch Intern Med; 1975 Jan; 135(1):125-30. PubMed ID: 1111461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytoma o' mice an' men.
    Hobbs JR
    Br Med J; 1971 Apr; 2(5753):67-72. PubMed ID: 4101482
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple myeloma--development of alternative malignancy following successful chemotherapy.
    Holt JM; Robb-Smith AH; Callender ST; Spriggs AI
    Br J Haematol; 1972 May; 22(5):633. PubMed ID: 4503794
    [No Abstract]   [Full Text] [Related]  

  • 12. [Benign and malignant monoclonal hypergammaglobulinemia (gammopathy)].
    Waldenström J
    Schweiz Med Wochenschr; 1970 Feb; 100(7):290-6. PubMed ID: 4189916
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of multiple myeloma.
    Waldenström J
    Br J Haematol; 1968 Sep; 15(3):217-20. PubMed ID: 5681477
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclophosphamide vs melphalan in treatment of plasma cell myeloma.
    Rivers SL; Patno ME
    JAMA; 1969 Feb; 207(7):1328-34. PubMed ID: 4179565
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lysosome evaluation in myeloma (author's transl)].
    Liso V; Troccoli G; Grande M
    Tumori; 1973; 59(4):303-5. PubMed ID: 4757085
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple myeloma and acute leukemia associated with alkylating agents.
    Kyle RA; Pierre RV; Bayrd ED
    Arch Intern Med; 1975 Jan; 135(1):185-92. PubMed ID: 1053891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of multiple myeloma.
    Malpas JS
    Br Med J; 1969 Apr; 2(5650):163-5. PubMed ID: 5778941
    [No Abstract]   [Full Text] [Related]  

  • 18. [Letter: Myeloma and myelo-monocytic leukemia. Role of melphalan].
    Marsan C; Henon P; Quillard A; Grimaldi A; Cywiner-Golener C
    Nouv Presse Med; 1973 Dec; 2(44):2958. PubMed ID: 4521337
    [No Abstract]   [Full Text] [Related]  

  • 19. Abnormal proteinuria in malignant diseases.
    Pruzanski W; Ogryzlo MA
    Adv Clin Chem; 1970; 13():335-82. PubMed ID: 4991600
    [No Abstract]   [Full Text] [Related]  

  • 20. Lysozyme in the serum, urine and peripheral blood leukocytes in patients with immunocytoma.
    Kraj M; Krzemińska-Lawkowiczowa I; Lawkowicz W; Krawczyński J; Sawicki Z; Mdzewski B; Cieśluk S; Czartoryska B; Górska D; Dmowska B
    Arch Immunol Ther Exp (Warsz); 1979; 27(6):875-88. PubMed ID: 121534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.